Skip to main content
Livermore
Livermore
ZHEN

Mirati Therapeutics, Inc.

MRTXDelisted Jan 23, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001576263

Mirati Therapeutics, Inc. was delisted on Jan 23, 2024; its insiders filed their last Form 4 on Jan 25, 2024; 218 institutions reported holding it in 13F filings for Q4 2023, worth $4.66B in total; no superinvestor held it.

13F holders, Q2 2024

Institutional positions in Mirati Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

MRTX is no longer listed, and 13F filings after Q4 2023 list far fewer holders. See Q4 2023

Institutional holders
0
−2 vs. Q1 2024
Shares held
0
−43 (−100.0%) vs. Q1 2024
Total value
$0
−$2.52K (−100.0%) vs. Q1 2024
New holders
0
0 more added
Sold out
2
0 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MRTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 0 institutions
Q1 2021: 260 institutionsQ2 2021: 245 institutionsQ3 2021: 239 institutionsQ4 2021: 260 institutionsQ1 2022: 252 institutionsQ2 2022: 231 institutionsQ3 2022: 243 institutionsQ4 2022: 233 institutionsQ1 2023: 222 institutionsQ2 2023: 207 institutionsQ3 2023: 215 institutionsQ4 2023: 218 institutionsQ1 2024: 2 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2024: $0
Q1 2021: $9.16BQ2 2021: $8.57BQ3 2021: $9.59BQ4 2021: $8.34BQ1 2022: $4.71BQ2 2022: $4.21BQ3 2022: $4.44BQ4 2022: $2.97BQ1 2023: $2.38BQ2 2023: $2.38BQ3 2023: $3.53BQ4 2023: $4.66BQ1 2024: $2.52KQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding MRTX and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20242$2.52K
Q4 2023218$4.66B
Q3 2023215$3.53B
Q2 2023207$2.38B
Q1 2023222$2.38B
Q4 2022233$2.97B
Q3 2022243$4.44B
Q2 2022231$4.21B
Q1 2022252$4.71B
Q4 2021260$8.34B
Q3 2021239$9.59B
Q2 2021245$8.57B
Q1 2021260$9.16B

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Mirati Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding MRTX in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Sachetta, LLC0$00.00%−24−100.0%Sold out
IFP Advisors, Inc0$00.00%−19−100.0%Sold out